Weisberg, E., Wright, R. D., Jiang, J., Ray, A., Moreno, D., Manley, P. W., . . . Griffin, J. D. (2006). Effects of PKC412, nilotinib and imatinib against GIST-associated PDGFRA mutants with differential imatinib sensitivity: Mutant PDGFRA: PKC412, nilotinib, imatinib.
Παραπομπή Chicago StyleWeisberg, Ellen, et al. Effects of PKC412, Nilotinib and Imatinib against GIST-associated PDGFRA Mutants With Differential Imatinib Sensitivity: Mutant PDGFRA: PKC412, Nilotinib, Imatinib. 2006.
Παραπομπή MLAWeisberg, Ellen, et al. Effects of PKC412, Nilotinib and Imatinib against GIST-associated PDGFRA Mutants With Differential Imatinib Sensitivity: Mutant PDGFRA: PKC412, Nilotinib, Imatinib. 2006.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.